About the Authors

Kayigan Wilson d’Almeida

kayigan.wilson@inserm.fr

Affiliations INSERM U1018, Centre de recherche en épidémiologie et santé des populations, Villejuif, France, Université. Versailles Saint-Quentin, Faculté de Médecine Paris Île-de-France Ouest, EA 4499, Paris, France

Dominique Pateron

Affiliation Service d’Accueil et de Traitement des Urgences, Hôpital Saint-Antoine, AP–HP, Paris, France

Gérald Kierzek

Affiliation Service d’Accueil et de Traitement des Urgences, Hôtel-Dieu Cochin, AP–HP, Paris, France

Bertrand Renaud

Affiliation Service d’Accueil et de Traitement des Urgences, Hôpital Henri Mondor, AP–HP, Créteil, France

Caroline Semaille

Affiliation Institut de Veille Sanitaire, St-Maurice, France

Pierre de Truchis

Affiliation Département de Médecine Aigüe Spécialisée, Hôpital Raymond-Poincaré, AP–HP, Garches, France

François Simon

Affiliation Service de Bactériologie–Virologie, Hôpital Saint-Louis, AP–HP, Paris, France

Judith Leblanc

Affiliation INSERM U1018, Centre de recherche en épidémiologie et santé des populations, Villejuif, France

France Lert

Affiliations INSERM U1018, Centre de recherche en épidémiologie et santé des populations, Villejuif, France, Université. Versailles Saint-Quentin, Faculté de Médecine Paris Île-de-France Ouest, EA 4499, Paris, France

Stéphane Le Vu

Affiliation Institut de Veille Sanitaire, St-Maurice, France

Anne-Claude Crémieux

Affiliations Université. Versailles Saint-Quentin, Faculté de Médecine Paris Île-de-France Ouest, EA 4499, Paris, France, Département de Médecine Aigüe Spécialisée, Hôpital Raymond-Poincaré, AP–HP, Garches, France

Competing Interests

Dr Anne-Claude Crémieux reported receiving grants from Janssen-Cilag, Novartis, AstraZeneca, Aventis and Haeraus for consultancies, workshops and travel to meetings and accommodations. Dr Pierre de Truchis reported receiving grants from Abbott, BMS, Gilead, MSD, Tibotec Janssen and ViiV Healthcare for workshops and travel to meetings and accommodations. Dr François Simon reported receiving grants from the French Health Products Safety Agency (Afssaps) for the evaluation of Orasure RTD. Rapid tests were provided free of charge by Orasure Technologies Inc., Bethlehem, Pennsylvania. There are no patents, products in development or marketed products to declare. The other authors have no disclosures to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.

Author Contributions

Conceived and designed the experiments: ACC KWdA FL FS SLV PdT BR GK DP JL CS. Performed the experiments: KWdA JL. Analyzed the data: ACC KWdA FL FS SLV PdT BR GK DP JL CS. Contributed reagents/materials/analysis tools: ACC KWdA FL FS SLV PdT BR GK DP JL CS. Wrote the paper: ACC KWdA FL FS SLV PdT BR GK DP JL CS.